Advanced gastric cancer | |||||||
---|---|---|---|---|---|---|---|
All | (n = 76) | Open | (n = 37) | Lap | (n = 39) | p | |
Demographics and preoperative features | |||||||
Sex (male) | 45 | (59) | 18 | (49) | 27 | (69) | 0.10 |
Age (years) | 77 | (73–83) | 76 | (73–81) | 77 | (73–83.5) | 0.40 |
BMI (kg/m2) | 24.2 | (21.9–26.8) | 25 | (22.3–27.4) | 23.9 | (21.9–26.1) | 0.40 |
Charlson comorbidity index | 1 | (1–2) | 1 | (1–2) | 1 | (1–2) | 0.40 |
ECOG score (> 1) | 21 | (28) | 10 | (27) | 11 | (28) | 0.99 |
ASA classification (> 2) | 17 | (22) | 8 | (22) | 9 | (23) | 0.99 |
GNRI (≤ 98) | 17 | (23) | 7 | (19) | 10 | (26) | 0.60 |
PNI (≤ 48) | 36 | (48) | 21 | (57) | 15 | (39) | 0.20 |
Clinical N+ stage | 46 | (61) | 26 | (70) | 20 | (51) | 0.11 |
Surgical procedure and adjuvant therapy | |||||||
Anastomotic type | 0.011* | ||||||
Billroth I | 42 | (55) | 15 | (41) | 27 | (69) | |
Billroth II | 30 | (39) | 18 | (49) | 12 | (31) | |
Roux-en-Y | 4 | (5.3) | 4 | (11) | 0 | (0) | |
Combined resection | 8 | (11) | 3 | (8.1) | 5 | (13) | 0.7 |
Adjuvant chemotherapy | 31 | (41) | 13 | (35) | 18 | (46) | 0.40 |